Triatomic Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,001
Closed -$223K 59
2023
Q3
$223K Hold
12,001
0.15% 47
2023
Q2
$304K Buy
+12,001
New +$302K 0.31% 40
2023
Q1
Sell
-17,000
Closed -$402K 66
2022
Q4
$402K Hold
17,000
0.34% 34
2022
Q3
$431K Hold
17,000
0.25% 35
2022
Q2
$565K Buy
17,000
+8,500
+100% +$361K 0.52% 28
2022
Q1
$613K Sell
8,500
-3,500
-29% -$252K 0.5% 31
2021
Q4
$1.1M Buy
+12,000
New +$1.43M 0.68% 30

Other funds holding TDOC

Triatomic Management's TDOC Position: Q4 2023 in Review

Triatomic Management sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 12,001 shares — an estimated $223K sold.

Triatomic Management first reported a position in TDOC in Q4 2021 and held it in 7 quarters. The position peaked at $1.1M in Q4 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Triatomic Management reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Triatomic Management sold 12,001 Teladoc Health shares in Q4 2023, an estimated $223K.
  • Triatomic Management first reported a position in Teladoc Health in Q4 2021 and held it in 7 quarters.
  • Triatomic Management's Teladoc Health position peaked at $1.1M in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Triatomic Management's 13F filing for Q4 2023, filed 13 Feb 2024.